• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Turn Therapeutics Inc. - Common Stock (NQ:TTRX)

4.620 -0.030 (-0.65%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,674
Open 4.550
Bid (Size) 4.600 (400)
Ask (Size) 4.740 (100)
Prev. Close 4.650
Today's Range 4.550 - 4.850
52wk Range 2.570 - 9.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
January 07, 2026
Mr. Dewhurst Brings Over 30 Years of Life Sciences and M&A Experience to the Board, Aligning with the Company’s Strategic Long-Term Goals for Growth and Expansion 
From Turn Therapeutics
Via GlobeNewswire
News headline image
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 13, 2025
From Turn Therapeutics
Via GlobeNewswire

Performance

YTD
-1.5%
-1.5%
1 Month
+37.5%
+37.5%
3 Month
-49.8%
-49.8%
6 Month
-34.0%
-34.0%
1 Year
-34.0%
-34.0%

More News

Read More
News headline image
Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine
November 11, 2025
From Turn Therapeutics
Via GlobeNewswire
Why Is Turn Therapeutics Stock Soaring Over 370% Premarket Today? ↗
October 09, 2025
Via Stocktwits
News headline image
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.
November 11, 2025
From Turn Therapeutics
Via GlobeNewswire
News headline image
Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications
November 04, 2025
From Turn Therapeutics
Via GlobeNewswire
News headline image
Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline
October 30, 2025
From Turn Therapeutics
Via GlobeNewswire
News headline image
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones
October 22, 2025
From Turn Therapeutics
Via GlobeNewswire
News headline image
Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025
October 20, 2025
From Turn Therapeutics
Via GlobeNewswire
News headline image
Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors
October 15, 2025
From Turn Therapeutics
Via GlobeNewswire
News headline image
Turn Therapeutics Appoints Arthur Golden to Board of Directors
October 14, 2025
From Turn Therapeutics
Via GlobeNewswire
News headline image
Dow Dips Over 250 Points; Delta Air Lines Posts Upbeat Earnings ↗
October 09, 2025
Via Benzinga
Topics Stocks
News headline image
US Stocks Mixed; Nasdaq Falls Over 50 Points ↗
October 09, 2025
Via Benzinga
News headline image
Stock Market Today: S&P 500, Nasdaq Futures Tumble As Fed Minutes Signal Tariff-Related Uncertainty—PepsiCo, Delta Air Lines, Levi Strauss In Focus ↗
October 09, 2025
Via Benzinga
Topics Economy Stocks
News headline image
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗
October 09, 2025
Via Benzinga
News headline image
PepsiCo, Delta Air Lines And 3 Stocks To Watch Heading Into Thursday ↗
October 09, 2025
Via Benzinga

Frequently Asked Questions

Is Turn Therapeutics Inc. - Common Stock publicly traded?
Yes, Turn Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Turn Therapeutics Inc. - Common Stock trade on?
Turn Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Turn Therapeutics Inc. - Common Stock?
The ticker symbol for Turn Therapeutics Inc. - Common Stock is TTRX on the Nasdaq Stock Market
What is the current price of Turn Therapeutics Inc. - Common Stock?
The current price of Turn Therapeutics Inc. - Common Stock is 4.620
When was Turn Therapeutics Inc. - Common Stock last traded?
The last trade of Turn Therapeutics Inc. - Common Stock was at 01/09/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap